This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Yoshimi Sato and the Cell Death Inhibitor Patent.
Introduction
Yoshimi Sato is an inventor associated with Ibaraki, Japan, and Takeda Pharmaceutical Company Limited. The supplied information identifies Sato as a woman and credits her with 1 patent.
Latest Patents
Sato’s listed patent is titled “Cell death inhibitor.” It describes a cell death inhibitor comprising a substance capable of binding to macrophage migration inhibitory factor. The patent presents the inhibitor as a potential preventive or therapeutic agent for a range of conditions, including heart and neurodegenerative diseases, cerebrovascular disorders, infections of the central nervous system, traumatic and demyelinating diseases, bone and joint disorders, kidney and liver diseases, arteriosclerosis, diabetes, pulmonary hypertension, sepsis, inflammatory bowel diseases, autoimmune diseases, transplant rejection, AIDS, and cancer.
Career Highlights
The available information connects Sato’s patent work with Takeda Pharmaceutical Company Limited. Her listed invention focuses on inhibiting cell death through a substance that binds to macrophage migration inhibitory factor.
Collaborations
Sato’s named coworkers include Haruhide Kimura and Masayauki Takizawa. The supplied details do not specify their individual roles in the patent.
Conclusion
Yoshimi Sato’s listed patent concerns a cell death inhibitor with potential applications across numerous disease areas, reflecting the breadth of the invention described in the patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile